Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-20

Clinical Trial Update: Azithromycin + Artesunate v Artemether-lumefantrine in Uncomplicated Malaria. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Azithromycin + Artesunate against Artemether-lumefantrine for uncomplicated malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)
  • Azithromycin + Artesunate

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 3 | Status: COMPLETED